Application of Large-Scale Aptamer-Based Proteomic Profiling to Planned Myocardial Infarctions

Abstract

Our results demonstrate the feasibility of large-scale aptamer multiplexing at a level that has not previously been reported and with sample throughput that greatly exceeds other existing proteomic methods. The expanded aptamer-based proteomic platform provides a unique opportunity for biomarker and pathway discovery after myocardial injury.